Inventor · disambiguated record
Kevin Mcgowan
Also filed as: MCGOWAN KEVIN · MCGOWAN KEVIN M
3 granted patents·2 pending applications·0 citations·filing 2004–2023
45Inventor score
Top patents by PatentIndex Score
5 records- 0172US12454519B2Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon proteinST JUDE CHILDRENS RES HOSPITAL INC·Filed 2023·Granted Oct 28, 2025·0 cites·26 claims
- 0265US12454518B2Substituted N-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamide analogs as modulators of cereblon proteinST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Granted Oct 28, 2025·0 cites·29 claims
- 0360US2025122166A1Substituted n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)methyl)benzamide analogs as modulators of cereblon proteinST JUDE CHILDRENS RES HOSPITAL INC·Filed 2022·Application pending·0 cites
- 0440US7834163B2Prostate specific genes and the use thereof as targets for prostate cancer therapyEXONHIT THERAPEUTICS SA·Filed 2004·Granted Nov 16, 2010·0 cites·5 claims
- 0537US2008254031A1Tumor Specific Genes and Variant Rnas and Uses Thereof as Targets for Cancer Therapy and DiagnosisEXONHIT THERAPEUTICS SA·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kevin Mcgowan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →